Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
/in Dendritic Cells, Glioblastoma, International PublicationsAnticancer effect of the oncolytic Newcastle disease virus harboring the PTEN gene on glioblastoma
/in Glioblastoma, International Publications, Newcastle Disease VirusA systematic review of immunotherapy in high-grade glioma: learning from the past to shape future perspectives
/in Dendritic Cells, Glioblastoma, International PublicationsGlioblastoma vaccines: past, present, and opportunities
/in Dendritic Cells, Glioblastoma, International PublicationsTargeting immunogenic cell death for glioma immunotherapy
/in Dendritic Cells, Glioblastoma, Immunogenic Cell Death, International PublicationsTherapeutic cell-based vaccines for glioblastoma multiforme
/in Dendritic Cells, Glioblastoma, International PublicationsMethods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Aktuelles, IOZK Veröffentlichungen, Newcastle Disease VirusClinical Applications of Immunotherapy for Recurrent Glioblastoma in Adults
/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease VirusDendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Aktuelles, IOZK Veröffentlichungen
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer